Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Lotz

Showing results (181-190 of 205) with videos related to

Pageof 21
Sort By:
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|August 10, 2012
Methylene blue modulates huntingtin aggregation intermediates and is protective in Huntington's disease modelsEmily Mitchell Sontag, Gregor P Lotz, Namita Agrawal, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 21, 2004
Gemcitabine combined with oxaliplatin (GEMOX) in advanced biliary tract adenocarcinoma: a GERCOR studyT André, C Tournigand, O Rosmorduc, et al.
Bioanalysis|August 18, 2020
European Immunogenicity Platform 11th Open Scientific Symposium on immunogenicity of biopharmaceuticalsSophie Tourdot, Carolina B Quaglia, Paul Chamberlain, et al.
International Journal of Radiation Oncology, Biology, Physics|February 16, 1999
Local recurrences and distant metastases after breast-conserving surgery and radiation therapy for early breast cancerE Touboul, L Buffat, Y Belkacémi, et al.
Frontiers in Immunology|June 17, 2024
Characterization of anti-drug antibody responses to the T-cell engaging bispecific antibody cibisatamab to understand the impact on exposureGregor P Lotz, Achim Lutz, Meret Martin-Facklam, et al.
Bone Marrow Transplantation|August 29, 2007
Recovery, viability and clinical toxicity of thawed and washed haematopoietic progenitor cells: analysis of 952 autologous peripheral blood stem cell transplantationsE Foïs, M Desmartin, S Benhamida, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 10, 2011
High-dose chemotherapy consolidation for chemosensitive advanced soft tissue sarcoma patients: an open-label, randomized controlled trialB Bui-Nguyen, I Ray-Coquard, C Chevreau, et al.
Bone Marrow Transplantation|February 28, 2006
Phase I study of high-dose topotecan with haematopoietic stem cell support in the treatment of ovarian carcinomas: the ITOV 01 protocolJ-P Lotz, P Pautier, F Selle, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 16, 2020
Successful pregnancy in a cancer patient previously cured of a gestational trophoblastic tumor by immunotherapyP-A Bolze, B You, J-P Lotz, et al.
Plos One|September 18, 2012
Fragments of HdhQ150 mutant huntingtin form a soluble oligomer pool that declines with aggregate deposition upon agingDavid Marcellin, Dorothee Abramowski, Douglas Young, et al.
Pageof 21

Showing results (181-190 of 205) with videos related to

Sort By:
Pageof 21
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|August 10, 2012
Methylene blue modulates huntingtin aggregation intermediates and is protective in Huntington's disease modelsEmily Mitchell Sontag, Gregor P Lotz, Namita Agrawal, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 21, 2004
Gemcitabine combined with oxaliplatin (GEMOX) in advanced biliary tract adenocarcinoma: a GERCOR studyT André, C Tournigand, O Rosmorduc, et al.
Bioanalysis|August 18, 2020
European Immunogenicity Platform 11th Open Scientific Symposium on immunogenicity of biopharmaceuticalsSophie Tourdot, Carolina B Quaglia, Paul Chamberlain, et al.
International Journal of Radiation Oncology, Biology, Physics|February 16, 1999
Local recurrences and distant metastases after breast-conserving surgery and radiation therapy for early breast cancerE Touboul, L Buffat, Y Belkacémi, et al.
Frontiers in Immunology|June 17, 2024
Characterization of anti-drug antibody responses to the T-cell engaging bispecific antibody cibisatamab to understand the impact on exposureGregor P Lotz, Achim Lutz, Meret Martin-Facklam, et al.
Bone Marrow Transplantation|August 29, 2007
Recovery, viability and clinical toxicity of thawed and washed haematopoietic progenitor cells: analysis of 952 autologous peripheral blood stem cell transplantationsE Foïs, M Desmartin, S Benhamida, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 10, 2011
High-dose chemotherapy consolidation for chemosensitive advanced soft tissue sarcoma patients: an open-label, randomized controlled trialB Bui-Nguyen, I Ray-Coquard, C Chevreau, et al.
Bone Marrow Transplantation|February 28, 2006
Phase I study of high-dose topotecan with haematopoietic stem cell support in the treatment of ovarian carcinomas: the ITOV 01 protocolJ-P Lotz, P Pautier, F Selle, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 16, 2020
Successful pregnancy in a cancer patient previously cured of a gestational trophoblastic tumor by immunotherapyP-A Bolze, B You, J-P Lotz, et al.
Plos One|September 18, 2012
Fragments of HdhQ150 mutant huntingtin form a soluble oligomer pool that declines with aggregate deposition upon agingDavid Marcellin, Dorothee Abramowski, Douglas Young, et al.
Pageof 21